Home › Funds › Farallon Capital Management › AVBP
Farallon Capital Management position in AVBP
ARRIVENT BIOPHARMA INC · Health Care
Latest position (Q1 2024)151.77K sh
Reported value held$2.71M
Portfolio Weight0.01%
First reportedQ1 2024
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 151.77K | $2.71M | New |
Other funds holding AVBP
- Hillhouse Capital (HHLR Advisors) 3.93M sh · $136.50M · Q2 2026
- BlackRock Inc 3.25M sh · $112.92M · Q2 2026
- Fidelity Management & Research (FMR) 2.78M sh · $96.54M · Q2 2026
- Vanguard Group 1.87M sh · $37.61M · Q4 2025
- Geode Capital Management 972.63K sh · $33.80M · Q2 2026
- D. E. Shaw & Co 872.01K sh · $30.29M · Q2 2026
- Goldman Sachs Group 853.72K sh · $29.66M · Q2 2026
- Point72 Asset Management 566.80K sh · $19.69M · Q2 2026
- Millennium Management 438.66K sh · $15.24M · Q2 2026
- UBS Group AG 438.59K sh · $15.24M · Q2 2026
- Balyasny Asset Management 395.45K sh · $13.74M · Q2 2026
- Northern Trust Corp 332.75K sh · $11.56M · Q2 2026